(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
Portfolio Pulse from Benzinga Insights
Iovance Biotherapeutics (NYSE:IOVA) has seen a 3.22% decrease in its short percent of float, now at 21.62%. This is higher than its peers' average of 14.60%. The decrease in short interest may indicate a shift in market sentiment.
September 03, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Iovance Biotherapeutics has experienced a 3.22% decrease in short interest, now at 21.62% of float, which is higher than its peers' average. This could indicate a shift in market sentiment towards the stock.
The decrease in short interest suggests that traders are less bearish on Iovance Biotherapeutics. With short interest still higher than peers, this could lead to a short squeeze if positive news emerges, potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100